REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Svencioniu Vaistazoles (Lithuania)

Main Activities: Coffee and Tea Manufacturing | Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Food Manufacturing | Coffee and Tea Manufacturing
Full name: UAB Svencioniu Vaistazoles Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Svencioniu Vaistazoles is an enterprise in Lithuania, with the main office in Svencionys. The company operates in the Coffee and Tea Manufacturing sector. The enterprise was incorporated on December 10, 1990. It currently has a total number of 109 (2025) employees. The latest financial highlights indicate a net sales revenue increase of 10.8% in 2024. UAB Svencioniu Vaistazoles’s net profit margin increased by 2.16% in 2024.

Headquarters
Adutiskio g. 3
Svencionys; Vilnius county; Postal Code: LT-18109

Contact Details: Purchase the UAB Svencioniu Vaistazoles report to view the information.

Basic Information
Total Employees:
Purchase the UAB Svencioniu Vaistazoles report to view the information.
Registered Capital:
Purchase the UAB Svencioniu Vaistazoles report to view the information.
Financial Auditors:
Purchase the UAB Svencioniu Vaistazoles report to view the information.
Incorporation Date:
December 10, 1990
Key Executives
Purchase this report to view the information.
Member of the Management Board
Subsidiaries
UAB Acorus Calamus
Company Performance
Financial values in the chart are available after UAB Svencioniu Vaistazoles report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
10.8%
Total operating revenue
10.8%
Net Profit (Loss) for the Period
164.74%
Total Equity
5.8%
Net Profit Margin
2.16%
Return on Equity (ROE)
3.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?